Cancers that have a deletion in the 9p21 section of their genomes tend to have worse outcomes for patients and increased resistance to immunotherapy. A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer. In mouse models of melanoma, bladder cancer, leukemia and colon cancer, the drug slows the growth of tumors, extends lifespan and boosts the efficacy of immunotherapy.
from Healthy Aging News -- ScienceDaily https://ift.tt/MHqXKFW
No comments:
Post a Comment